Skip to content
Screener

Alkermes ALKS Inventories

Inventories at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$2.74B0.0%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$437.5M-11.2%
AbbVie logo
AbbVieABBV
$5.05B+11.6%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$31.52M+93.1%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$1M-91.7%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$5.28M-17.3%

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemJune 30, 2026December 31, 2025
Restricted cash731,206
Investments—short-term145,048199,645
Receivables, net456,477334,025
Inventory298,957196,625
Prepaid expenses and other current assets110,89579,090
Total current assets1,522,9061,929,161
PROPERTY, PLANT AND EQUIPMENT, NET218,284221,722
INVESTMENTS—LONG-TERM35,054145

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's inventories?
Alkermes (ALKS) reported inventories of $298.96M in Q2 2026.
How has Alkermes's inventories changed year-over-year?
Alkermes's inventories increased by 55.8% year-over-year, from $191.92M to $298.96M.
What is the long-term trend for Alkermes's inventories?
Over 5 years (2020 to 2025), Alkermes's inventories has grown at a 9.4% compound annual growth rate (CAGR), from $125.74M to $196.63M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

Ask your AI about Alkermes's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude